NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.

Mol Oncol · 2020 · PMC7053236 · PMID 31854063

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

tended toward significanceno p-value reported

The percentage of ‘actionable patients’ in the class of HER/EGFR inhibitors was higher in IBC (36% vs 23%), and the difference tended toward significance in MV including the molecular subtypes and AJCC stage.

also in 121 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.